Arcadia Enables High-Value Care with Advanced Interoperability and AI Solutions
BOSTON, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Arcadia® ( arcadia.io), a leading data platform for healthcare, today launched new solutions designed to help payers and providers drive high-performing networks, simplify value-based care contract creation, and enhance provider management efforts. The data platform company also unveiled an analyst-friendly AI development platform that activates customer data to deliver predictive insights that drive actions that improve patient outcomes. Arcadia will showcase these innovations at HIMSS25 and demonstrate how its platform delivers actionable insights and measurable results.
Driving High-Value Care Through Complete Data and Advanced Analytics
Delivering on the promise of Arcadia's strategic acquisition of CareJourney in June 2024, the company's solutions support high-value care by running on a differentiated foundation of complete data:
Third-party benchmarks data from CareJourney that helps identify performance improvement opportunities
Customers' own data aggregated by Arcadia in its data platform that helps customers act on those opportunities
With a commitment to standards-based interoperability, Arcadia enables rapid data acquisition and aggregation of complete data at scale and in a single platform. Research shows that the average physician practice manages over 20 health plan contracts1 while the average health system maintains nearly the same amount of EHR instances across its networks.2 Without seamless solutions that exchange and house such data, insights that drive action to improve clinical and financial outcomes are lost.
In addition to building longitudinal patient records in a timely and cost-effective manner, Arcadia layers on advanced analytics applications — including those powered by AI — to enable its customers to derive insights that power strategies like:
Improving revenue through engaged and happy patients, which supports higher star ratings
Controlling costs by developing a network of providers that exceed cost and quality benchmarks
Driving efficiency and productivity by stratifying patients to help care managers focus in the right places
'Delivering complete data in a single platform helps our customers realize the strongest return on their data investments, including immediate value on day one,' said Michael Meucci, Arcadia's President and CEO. 'That value increases over time as our solutions for value-based care serve as the groundwork for our industry's future.'
Showcasing the Latest Innovations at HIMSS25
At HIMSS25, Arcadia will introduce several of its latest innovations designed to support healthcare organizations in their pursuit of operational and performance excellence:
Network Modeler: A tool powered by a database of intelligence on more than 745,000 providers nationwide that healthcare organizations can use to design, build, and evaluate networks. The solution enables organizations to use data to confidently expand into new geographies, manage existing networks more effectively, and gain visibility into population statistics to help ensure quality care, care gap closure, cost efficiency, and an improved member experience.
Contract IQ: A tool that simplifies the design, negotiation, and forecasting of value-based care contracts. Collaborate with stakeholders in a unified interface, forecast revenue through 'what-if' tools, and automate manual contracting processes. With Arcadia's Contract IQ, organizations can reduce third-party actuarial spending by up to $60,000 a month, improve returns on VBC contracts, and increase revenue predictability.3
'We manage more than a dozen contracts with half a dozen payers, which places a burden on our team to reconcile those contracts and make sure we're getting credit where credit is due,' said Julie Grantz, Vice President of Value-Based Insights at Ochsner Health Network. 'Arcadia's ContractIQ helps us forecast performance during the year so we can course correct well in advance of receiving final results.'
Provider Intelligence: A significant enhancement to our analytics engine that extracts insights from first-party claims data across 250+ episodes of care. When paired with population insights from comprehensive national benchmarks, healthcare organizations can improve care team effectiveness by identifying opportunities to intervene quickly. For example, a provider can identify a patient starting a congestive heart failure episode and act promptly to avoid gaps in care that could lead to poor outcomes, high utilization, and avoidable events.
AI Factory: An analyst-friendly AI development platform powered by Arcadia's proprietary healthcare data asset to predict patients' needs so care teams can act without delay or uncertainty. Analysts can use the tool to build and train their own models or customize existing models to identify patients with disease progression, rising risk, and the likelihood of an adverse event. For example, analytics can identify patients with chronic kidney disease who begin dialysis without proper treatment from a nephrologist and feed that to care teams regularly so they can prioritize care management efforts.
'Arcadia's ability to aggregate, harmonize, and analyze complex healthcare datasets enables clients to identify at-risk populations, implement precision medicine strategies, and enhance financial sustainability through data-driven decision-making,' said Black Book Research, which recently named Arcadia #1 in population health data integration and analytics. 'Clients noted significant advancements in their data maturity, increased operational efficiencies, and improved financial performance as direct results of Arcadia's expertise in analytics-driven healthcare transformation.'
Visit Arcadia at HIMSS25
Schedule a meeting with Arcadia at HIMSS25 (booth #3510) to learn how you can drive savings, improve outcomes, and identify opportunities to grow your network with one streamlined analytics platform.
1
2 When health records don't capture patient deaths, Lown Institute, 2024
3 Arcadia analysis of market data, 2024
Arcadia helps payers and providers put their data to work so they can transform healthcare. We do that through an interoperable data platform that uses advanced analytics to shape strategies, inform decisions, and facilitate actions. In turn, payers and providers can focus on what matters most — whether that's patient outcomes, operational efficiencies, or financial performance. We're trusted by the institutions driving the future of healthcare, including Southwestern Health Resources, Tandigm, Castell, Rush Health, and Beth Israel Lahey Health. To learn how Arcadia is shaping the future of healthcare with innovative solutions that deliver data-driven insights, visit arcadia.io.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
4 hours ago
- Business Upturn
Bitcoin Solaris Presale Surges Past $3.8M as Final $6 Phase Nears Close
By GlobeNewswire Published on June 8, 2025, 16:11 IST TALLINN, Estonia, June 08, 2025 (GLOBE NEWSWIRE) — The crypto community is buzzing as Bitcoin Solaris (BTC-S) crosses a major milestone, raising $3.8 million in its ongoing presale. With over 11,000 participants already onboard and the token price still at just $6, this marks one of the most rapid early-stage raises of 2025. Built with a clear focus on speed, decentralization, and developer-ready infrastructure, Bitcoin Solaris is more than just another token—it's a full-stack blockchain ecosystem gearing up for mainnet launch. The current phase of the presale is expected to end within days, ahead of the next price jump to $7. Why Bitcoin Solaris Is Outpacing the Crypto Pack Bitcoin Solaris was built to take the best of each and leave the problems behind. Here's how it does that: Combines Proof-of-Work and Delegated Proof-of-Stake for a dual-consensus model. Runs up to 100,000 TPS on the Solaris Layer, with 2-second finality. Secures its Base Layer with SHA-256, keeping it compatible with existing mining rigs. Includes 21 rotating validators, ensuring decentralization with performance. Why Everyone Is Talking About It From top Telegram groups to influencer channels, the buzz around Bitcoin Solaris is only growing. The detailed breakdown by Ben Crypto highlights why this project stands out in a sea of overpromises. With real use cases, deep audits, and a scalable structure, the hype isn't artificial—it's earned. What makes this even more incredible? The presale isn't even over yet. Current phase: 6 (last day) Current price: $6 Next phase: $7 Launch price: $20 Potential return: 1,900% Already raised: $3.8 million This is being hailed as one of the shortest and most explosive presales in recent memory, and the countdown has officially begun. Core Features That Power the Frenzy At the heart of Bitcoin Solaris is one idea: speed without compromise. Let's break down why it's different: Hybrid PoW/DPoS Consensus: Maintains decentralization while enabling speed. Validator Rotation: Every 24 hours, keeping the system agile and secure. Energy Efficiency: Uses 99.95% less power than Bitcoin. Cross-Chain Bridges: Built-in support for interoperability with Solana and others. Rust-Based Smart Contracts: Initially leveraging Solana tools for dApps and DeFi expansion. Audited Infrastructure: Smart contracts have been fully reviewed by Cyberscope and Freshcoins for trust and security. This Is How Bitcoin Solaris Will Make People Rich Wealth isn't made by buying late. It's built by spotting what's early—but solid. Bitcoin Solaris isn't a copycat. It's a new layer of infrastructure designed to generate value for real participants. The reward distribution model ensures that every piece of the network feeds back into the community: 40% of rewards go to miners 25% go to validators 20% go to stakers 10% funds for long-term development 5% support community initiatives Unlike many coins where wealth consolidates at the top, BTC-S is structured to empower long-term holders, contributors, and those who participate early. Real Vision, Real Roadmap Bitcoin Solaris isn't pitching hope—it's executing a plan. Here's the official roadmap: Bitcoin Solaris Roadmap Summary Phase 1 (Q2–Q4 2025): Token generation, whitepaper, core devs, and presale launch Phase 2 (Q1 2026): Testnet, wallet, bridge integration, architecture optimization Phase 3 (Q2 2026): Final mainnet prep, dev tools, exchange listings Phase 4 (Q3 2026): Mainnet launch, AI-powered app release, governance rollout Phase 5 (Q4 2026): DApp accelerator, Mining Power Marketplace, hardware wallet integration Phase 6 (Q1–Q2 2027): Layer-2 upgrades, DEX, and quantum security Phase 7 (Q3–Q4 2027): Fortune 500 partnerships, institutional tools, Innovation Labs Phase 8 (2028+): AI integration, government collaborations, long-term evolution That's not just a vision board—it's an execution framework already in motion. The Final Surge Is On Bitcoin Solaris isn't just another token looking for attention. It's a serious infrastructure play backed by smart tech, audited code, and a growing army of supporters. With $3.8 million raised and momentum accelerating, this is one of the few presales that feels like more than a hype train. And with the price still sitting at just $6 for a very short time—this might be the final opportunity to ride the wave before it takes off. For more information on Bitcoin Solaris: Website: Telegram: X: Media ContactXander Levine [email protected] Press Kit: Available upon request Disclaimer: This is a paid post and is provided by Bitcoin Solaris . The statements, views, and opinions expressed in this content are solely those of the content provider and do not necessarily reflect the views of this media platform or its publisher. We do not endorse, verify, or guarantee the accuracy, completeness, or reliability of any information presented. We do not guarantee any claims, statements, or promises made in this article. This content is for informational purposes only and should not be considered financial, investment, or trading in crypto and mining-related opportunities involves significant risks, including the potential loss of capital. It is possible to lose all your capital. These products may not be suitable for everyone, and you should ensure that you understand the risks involved. Seek independent advice if necessary. Speculate only with funds that you can afford to lose. Readers are strongly encouraged to conduct their own research and consult with a qualified financial advisor before making any investment decisions. However, due to the inherently speculative nature of the blockchain sector—including cryptocurrency, NFTs, and mining—complete accuracy cannot always be the media platform nor the publisher shall be held responsible for any fraudulent activities, misrepresentations, or financial losses arising from the content of this press release. In the event of any legal claims or charges against this article, we accept no liability or responsibility. Globenewswire does not endorse any content on this page. Legal Disclaimer: This media platform provides the content of this article on an 'as-is' basis, without any warranties or representations of any kind, express or implied. We assume no responsibility for any inaccuracies, errors, or omissions. We do not assume any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information presented herein. Any concerns, complaints, or copyright issues related to this article should be directed to the content provider mentioned above. Photos accompanying this announcement are available at: Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. GlobeNewswire provides press release distribution services globally, with substantial operations in North America and Europe.
Business Upturn
4 hours ago
- Business Upturn
URGN INVESTOR NEWS: UroGen Pharma Ltd. has been Sued for Securities Fraud – Contact BFA Law before July 28 Deadline (NASDAQ:URGN)
NEW YORK, June 08, 2025 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against UroGen Pharma Ltd. (NASDAQ: URGN) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in UroGen you are encouraged to obtain additional information by visiting Investors have until July 28, 2025, to ask the Court to be appointed to lead the case. The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors who purchased UroGen securities. The case is pending in the U.S. District Court for the District of New Jersey and is captioned: Cockrell v. UroGen Pharma Ltd., et al. , No. 3:25-cv-06088. Why was UroGen Sued for Securities Fraud? UroGen develops treatments for specialty cancers. The Company's lead pipeline product is UGN-102 (mitomycin), an intravesical solution intended to treat low-grade intermediate risk non-muscle invasive bladder cancer. One of the Phase 3 trials for UGN-102 is named ENVISION. As alleged, UroGen stated that the ENVISION trial met its primary endpoint and that UroGen had reached 'agreement with the FDA' that the ENVISION trial would support an NDA submission. In truth, the FDA had previously expressed significant concerns to UroGen regarding the ENVISION trial, which lacked a concurrent control arm. The Stock Declines as the Truth is Revealed On May 16, 2025, the FDA published a briefing document stating that it doubted whether the submitted data was sufficient to conclude that UGN-102 was effective. FDA stated that because 'ENVISION lacked a concurrent control arm,' the primary endpoints were 'difficult to interpret' and that UroGen 'chose not to conduct a randomized trial with a design and endpoints that the FDA considered appropriate.' On this news, the price of UroGen stock declined $2.54 per share, or nearly 26%, from a closing price of $9.85 per share on May 15, 2025, to $7.31 per share on May 16, 2025. Then, on May 21, 2025, the Oncologic Drugs Advisory Committee voted against approving the UGN-102 NDA, finding that the overall benefit-risk profile of UGN-102 was not favorable in patients with recurrent low-grade, intermediate-risk non-muscle invasive bladder cancer. On this news, the price of UroGen stock declined $3.37 per share, or nearly 45%, from a closing price of $7.54 per share on May 20, 2025, to $4.17 per share on May 21, 2025. Click here if you suffered losses: What Can You Do? If you invested in UroGen you may have legal options and are encouraged to submit your information to the firm. All representation is on a contingency fee basis, there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses. Submit your information by visiting: Or contact:Ross Shikowitz [email protected] 212-789-3619
Business Upturn
4 hours ago
- Business Upturn
Where the Sea Meets the Skin: Shapellx Unveils Innovative New OceanHug™ Collection Made from Oyster Shells
By GlobeNewswire Published on June 8, 2025, 18:00 IST ORLANDO, Fla., June 08, 2025 (GLOBE NEWSWIRE) — Shapellx , a leading women's shapewear brand, proudly announces the launch of OceanHug™ – a seamless women's wear collection of intimates, outerwear, and shapewear pieces crafted with a first-of-its-kind fabric made from recycled oyster shells. The new sustainable, ocean-inspired collection enhances body contours while delivering the perfect balance of style, comfort, and sustainability. Every year, millions of pounds of oyster shells are discarded, eventually ending up in landfills. Shapellx believes that beauty should never come at the expense of the environment. Every OceanHug™ piece gives new purpose to 33 recycled oyster shells, integrating them into ethically produced, performance-driven fabrics. By turning marine waste into innovation, the collection represents a fresh take on circular fashion by finding a second life for shells that promotes innovation while reducing use of virgin materials. 'As sustainability becomes a top priority for both brands and consumers, Shapellx is proud to lead with innovative materials like oyster protein that combine environmental responsibility with performance-enhancing benefits,' said Shane Shi, Vice President of Shapellx. 'We're committed to delivering more sustainable alternatives without compromising on quality or comfort. OceanHug™ is just the beginning.' The lightweight yet form-fitting OceanHug™ yarn is engineered with breathable, moisture-wicking properties, feeling silky, cool, and comfortable to the touch. The fabric uniquely incorporates collagen peptides and oyster protein fiber, rich in amino acids and trace elements, which can help to nourish the skin and strengthen its barrier. OceanHug™ also offers antibacterial properties, reducing harmful bacteria growth by 2.56%, and is specially processed to be free from irritating chemicals, making it an excellent choice for those with sensitive skin. The new lineup, built with shapewear materials to hug and comfortably embrace the body, comes in soft hues of baby blue, lavender pink, oyster white, and more. The collection includes the following products: OceanHug™ Oyster Reborn Smoothing Bodysuit The delicate lace cup edges expand the coverage around the bust, enhancing the natural bust shape and curve. The waist and abdomen shaping works to tighten and smooth targeted areas for a comfortable, sculpted silhouette. Retails for $54 and is available in sizes S-XXL and colors black, brown, baby blue, oyster white, lavender pink and bright red. OceanHug™ Oyster Reborn T-Shirt Bra The OceanHug ™ Seamless Bra is made with high-elasticity yarn and butter-soft fabric for an ultimate comfort experience. The fixed one-piece cup design reduces the risk of cup-shifting for a supportive fit. The back closure is 7cm wide, compared to the traditional 3.5cm, providing better wraparound coverage and enhanced smoothing. Retails for $49 and is available in sizes S-3XL and colors black, brown, baby blue, oyster white, beige and lavender pink. OceanHug™ Oyster Reborn Smoothing Brief The briefs feature a mid-waist, hip-hugging seamless design for stable coverage, preventing unwanted digging and squeezing while delivering stretch to fit perfectly on all body types. Made from skin-friendly, soft modal fabric, it provides a gentle and refreshing touch on the skin. Retails for $9 and is available in sizes S-3XL and colors black, brown, baby blue, oyster white, beige and lavender pink. OceanHug™ Oyster Reborn Smoothing Cami The V-neckline highlights the collarbone, creating a feminine, flattering look. The built-in 3D molded cups comfortably lift and shape the bust for all-day support. It features an anti-slip grip at the bottom hem to prevent rolling and ensure a smooth, stable fit. The compression fabric around the waist and abdomen smooths the area and provides comfortable shaping. Retails for $49 and is available in sizes S-XXL and colors black, brown, baby blue, oyster white, beige and lavender pink. To celebrate both the OceanHug™ launch and World Ocean Day on June 8, Shapellx hosted a pop-up event in NoHo, New York. Attendees were able to experience the OceanHug™ fabric firsthand and received a special gift. Designed to suit your everyday life and standout moments, Shapellx's new OceanHug™ collection is available to purchase at . To learn more about the collection and keep up with the brand, follow along on Instagram and TikTok . About Shapellx Shapellx is a full-category shapewear brand built on cutting-edge shaping technology and refined design aesthetics. Through premium international retailers such as Nordstrom and its own online platform, Shapellx connects with women who value both quality and style. The brand is dedicated to meeting the dual needs of fashion expression and body contouring in everyday wear, empowering women to radiate confidence from the inside out. Contact:Melina Schaefer [email protected] A video accompanying this announcement is available at Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. GlobeNewswire provides press release distribution services globally, with substantial operations in North America and Europe.
